Mesoblast Limited
MEOBF
$1.55
-$0.04-2.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.21% | 16.21% | 2.18% | 2.18% | -47.31% |
| Total Depreciation and Amortization | 107.06% | 107.06% | 94.29% | 94.29% | -14.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.80% | -8.80% | -20.69% | -20.69% | 213.73% |
| Change in Net Operating Assets | -4,471.28% | -4,471.28% | -232.53% | -232.53% | 91.58% |
| Cash from Operations | -46.91% | -46.91% | -33.87% | -33.87% | 22.27% |
| Capital Expenditure | -298.11% | -298.11% | -645.45% | -645.45% | 45.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -125.24% | -125.24% | -1.47% | -1.47% | 591.51% |
| Cash from Investing | -196.81% | -196.81% | -5,533.33% | -5,533.33% | 812.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,869.21% | -1,869.21% | 45.63% | 45.63% | -66.85% |
| Issuance of Common Stock | 313.94% | 313.94% | 542.23% | 542.23% | -96.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -272.85% | -272.85% | -27.98% | -27.98% | 66.02% |
| Cash from Financing | 73.55% | 73.55% | 1,652.20% | 1,652.20% | -113.49% |
| Foreign Exchange rate Adjustments | 178.72% | 178.72% | 227.91% | 227.91% | -149.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.65% | -26.65% | 946.39% | 946.39% | -499.79% |